An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

NCT00005001 ·Status: COMPLETED ·Phase: PHASE2

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

NCT00021762 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002005 ·Status: COMPLETED ·Phase: NA

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

NCT00058734 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

NCT00000755 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers

NCT00001992 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

NCT00311688 ·Status: COMPLETED

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

NCT03856996 ·Status: COMPLETED ·Phase: PHASE1

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

NCT02389595 ·Status: ACTIVE_NOT_RECRUITING

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

NCT00001056 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

NCT00119873 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

NCT00006153 ·Status: TERMINATED ·Phase: PHASE1

Study Evaluating Vaccine in Adults With HIV

NCT00195234 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

NCT00000779 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

NCT00000857 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

NCT00005002 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

NCT00110578 ·Status: COMPLETED ·Phase: PHASE1

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

NCT00107549 ·Status: COMPLETED ·Phase: PHASE1

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection

NCT01009762 ·Status: COMPLETED ·Phase: PHASE1

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

NCT00672932 ·Status: COMPLETED ·Phase: NA